0001821825-24-000049.txt : 20240403
0001821825-24-000049.hdr.sgml : 20240403
20240403184208
ACCESSION NUMBER: 0001821825-24-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WALSH MATTHEW M
CENTRAL INDEX KEY: 0001269428
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40235
FILM NUMBER: 24820739
MAIL ADDRESS:
STREET 1: ALLERGAN
STREET 2: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organon & Co.
CENTRAL INDEX KEY: 0001821825
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464838035
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
BUSINESS PHONE: 551-430-6000
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
4
1
wk-form4_1712184118.xml
FORM 4
X0508
4
2024-03-31
0
0001821825
Organon & Co.
OGN
0001269428
WALSH MATTHEW M
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33
JERSEY CITY
NJ
07302
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-03-31
4
M
0
7753
0
A
81815
D
Common Stock
2024-03-31
4
F
0
3819
18.80
D
77996
D
Common Stock
2024-03-31
4
M
0
12046
0
A
90042
D
Common Stock
2024-03-31
4
F
0
5933
18.80
D
84109
D
Restricted Stock Units
2024-03-31
4
M
0
7753
0
D
Common Stock
7753
7754
D
Restricted Stock Units
2024-03-31
4
M
0
12046
0
D
Common Stock
12046
24093
D
Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
2024-04-03